Emmanuel Khalifa
Emmanuel Khalifa is an expert in Oncology at Institut Bergonié (France). Emmanuel Khalifa has authored 27 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 78 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Genetics - Histology - Gynecology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2015 - 2026
Number : 27
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors from Whole-Slide Images. PMID 42258704 — gastrointestinal stromal tumors, neoplasms, exons, deep learning, protein-tyrosine kinases, tyrosine, therapeutics, learning, mutation, landslides | Cancer Res | 2026 | 0 |
| Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 patients. PMID 39729677 — neoplasms, adenocarcinoma, biopsy, therapeutics, tissues, liquid biopsy, mutation | Eur J Cancer | 2024 | 0 |
| Are DNA Repair Gene Alterations Associated With the Response to Platinum-Based Regimen and Immune Checkpoint Inhibitors in Patients With Solid Tumors? PMID 38558248 — genes, dna repair, progression-free survival, neoplasms, drug therapy, immune checkpoint inhibitors, precision medicine, chemotherapy | Oncologist | 2024 | 1 |
| Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls. PMID 37988282 — immunohistochemistry, fibrosarcoma, neoplasms, pathology, sarcoma, histology, sarcoma, endometrial stromal, uterine neoplasms, tissues, cervix uteri | Histopathology | 2023 | 15 |
| Idylla assay on extracted DNA: advantages, limits and place in molecular screening according to the latest guidelines for non-small-cell lung cancer (NSCLC) patients. PMID 35820776 — pathology, clinical, cells, high-throughput nucleotide sequencing, lung, molecular biology, neoplasms, pathology, molecular, carcinoma, non-small-cell lung, lung neoplasms, biomarkers, tumor, small cell lung carcinoma, diagnostic screening programs, tissues, dna, mutation | J Clin Pathol | 2022 | 7 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
LeadR Networks
Main global connection map